Biblio Discovery — Demo Discovery Service

11 hasil untuk "Pollack, Scott"

Menampilkan 1–11 · 0,48 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Deep Anterior Lamellar Keratoplasty Over Penetrating Keratoplasty to Mitigate Positive Vitreous Pressure Complications

    Moumneh, Khaled; Pollack, Scott; Perich, Larry M

    Cureus · 2023 · Inggris · PubMed Central

    This report describes deep anterior lamellar keratoplasty over penetrating keratoplasty (DALK-over-PKP) as an alternative technique to mitigate complications related to positive vitreous pressure (PVP) during PKP. We accomplished this by repairing the punctured cornea and performing a modified DALK…

  2. Artikel Jurnal Teks lengkap

    Mesalamine induced symptom exacerbation of ulcerative colitis: Case report and brief discussion

    Gupta, Maneesh Kumar; Pollack, Scott; Hutchings, John J

    World J Gastrointest Pharmacol Ther · 2010 · Inggris · PubMed Central

    This paper describes a rare case in which the oral administration of mesalamine resulted in the exacerbation of ulcerative colitis (UC) in a patient who was previously responsive to mesalamine and whose colitis had been in remission for eight years. Mesalamine and other 5-aminosalicylic acid…

  3. Artikel Jurnal Teks lengkap

    The antibody TBL‐100 binds with picomolar affinity and high specificity to the free carboxy terminus of tauC3 in tau oligomers involved in spreading of pathology in AD

    Yahya, Norhakim; Pollack, Scott J; Margolin, Richard dkk.

    Alzheimers Dement · 2025 · Inggris · PubMed Central

    BACKGROUND: Tau abnormalities are central to AD and non‐AD tauopathies, including FTD and PSP. Several tau antibodies tested through Phase 2 have not demonstrated clinical benefit. Potential explanations include affinities too weak for effective target engagement and lack of specificity for toxic…

  4. Artikel Jurnal Teks lengkap

    Recruiting U.S. and Canadian College Students via Social Media for Participation in a Web-Based Brief Intervention Study

    Fazzino, Tera L; Rose, Gail L; Pollack, Scott M dkk.

    J Stud Alcohol Drugs · 2015 · Inggris · PubMed Central

    OBJECTIVE: Recruiting young adults for health research is challenging. Social media provides wide access to potential research participants. We evaluated the feasibility of recruiting students via free message postings on Facebook and Twitter to participate in a web-based brief intervention study…

  5. Artikel Jurnal Teks lengkap

    AlphaFold 2 predicts a markedly different MTBR conformation for 3‐repeat and 4‐repeat tau isoforms

    Chain, Daniel G; Margolin, Richard A; Pollack, Scott dkk.

    Alzheimers Dement · 2025 · Inggris · PubMed Central

    BACKGROUND: Tau abnormalities are a central feature of Alzheimer’s disease (AD) and the defining feature of non‐AD tauopathies, which include frontotemporal lobar degeneration (FTLD) due to Pick’s disease (PiD) or Mapt mutations (FTLD‐tau), as well as progressive supranuclear palsy (PSP)…

  6. Artikel Jurnal Teks lengkap

    Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex

    Tollenaere, Maxim A.X.; Mølck, Christina; Henderson, Ian dkk.

    JID Innov · 2023 · Inggris · PubMed Central

    Tralokinumab, a fully human mAb specifically targeting the IL-13 cytokine, has demonstrated clinical efficacy and safety in patients with moderate-to-severe atopic dermatitis. Tralokinumab binds IL-13 with high affinity, which prevents the interaction of IL-13 with IL-13Rα1 and subsequent…

  7. Artikel Jurnal Teks lengkap

    Discovery, Synthesis and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3

    Goodfellow, Val S.; Loweth, Colin J.; Ravula, Satheesh B. dkk.

    J Med Chem · 2013 · Inggris · PubMed Central

    Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson’s Disease and HIV-1 Associated Neurocognitive Disorders (HAND), requiring an inhibitor that can achieve significant brain concentration levels. We report here URMC-099 (1) an orally bioavailable (F =…

  8. Artikel Jurnal Teks lengkap

    A comparative study of fragment screening methods on the p38α kinase: new methods, new insights

    Pollack, Scott J.; Beyer, Kim S.; Lock, Christopher dkk.

    J Comput Aided Mol Des · 2011 · Inggris · PubMed Central

    The stress-activated kinase p38α was used to evaluate a fragment-based drug discovery approach using the BioFocus fragment library. Compounds were screened by surface plasmon resonance (SPR) on a Biacore(™) T100 against p38α and two selectivity targets. A sub-set of our library was the focus of…

  9. Artikel Jurnal Teks lengkap

    Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors

    Luckhurst, Christopher A.; Breccia, Perla; Stott, Andrew J. dkk.

    ACS Med Chem Lett · 2015 · Inggris · PubMed Central

    [Image: see text] Potent and selective class IIa HDAC tetrasubstituted cyclopropane hydroxamic acid inhibitors were identified with high oral bioavailability that exhibited good brain and muscle exposure. Compound 14 displayed suitable properties for assessment of the impact of class IIa HDAC…

  10. Artikel Jurnal Teks lengkap

    Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington’s Disease

    Stott, Andrew J.; Maillard, Michel C.; Beaumont, Vahri dkk.

    ACS Med Chem Lett · 2021 · Inggris · PubMed Central

    [Image: see text] Using an iterative structure–activity relationship driven approach, we identified a CNS-penetrant 5-(trifluoromethyl)-1,2,4-oxadiazole (TFMO, 12) with a pharmacokinetic profile suitable for probing class IIa histone deacetylase (HDAC) inhibition in vivo. Given the lack of…

  11. Artikel Jurnal Teks lengkap

    Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B

    Vögtle, Timo; Sharma, Sumana; Mori, Jun dkk.

    eLife · 2019 · Inggris · PubMed Central

    The immunoreceptor tyrosine-based inhibition motif (ITIM)-containing receptor G6b-B is critical for platelet production and activation. Loss of G6b-B results in severe macrothrombocytopenia, myelofibrosis and aberrant platelet function in mice and humans. Using a combination of…